{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:02:21Z","timestamp":1782756141924,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100032477","name":"Alanya Alaaddin Keykubat University","doi-asserted-by":"crossref","award":["2023\u201315\u201301-MAP01"],"award-info":[{"award-number":["2023\u201315\u201301-MAP01"]}],"id":[{"id":"10.13039\/100032477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03218-x","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:52:18Z","timestamp":1766854338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the possible effects of LncRNA CYTOR on the molecular mechanisms of metastasis and Hippo signaling pathways in Triple-negative and Cisplatin-resistant breast cancer cell lines"],"prefix":"10.1007","volume":"43","author":[{"given":"Emine","family":"Erda\u011f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Ergene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"3218_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2020.06.019","volume":"72","author":"I Amelioa","year":"2021","unstructured":"Amelioa I, Bernassolaa BF, Candi E. Emerging roles of long non-coding RNAs in breast cancer biology and management. Semin Cancer Biol. 2021;72:36\u201345.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"3218_CR2","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1158\/0008-5472.CAN-09-0099","volume":"69","author":"J Lu","year":"2009","unstructured":"Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Yu D. Breast cancer metastasis: challenges and opportunities. Cancer Res. 2009;69(12):4951\u20133.","journal-title":"Cancer Res"},{"issue":"1","key":"3218_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ncrna5010017","volume":"5","author":"JC Fernandes","year":"2019","unstructured":"Fernandes JC, Acua SM, Aoki JI, Floeter-Winter LM, Muxel SM. Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease. Non-coding RNA. 2019;5(1):17.","journal-title":"Non-coding RNA"},{"key":"3218_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033819843889","volume":"18","author":"T Zhang","year":"2019","unstructured":"Zhang T, Hu H, Yan G, Wu T, Liu S, Chen W, et al. Long non- coding RNA and breast cancer. Technol Cancer Res Treat. 2019;18:1\u201310. https:\/\/doi.org\/10.1177\/1533033819843889","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"3218_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ncrna.2020.11.004","volume":"5","author":"P Mondal","year":"2020","unstructured":"Mondal P, Meeran SM. Long non-coding RNAs in breast cancer metastasis. Noncoding RNA Res Nov. 2020;5(4):208\u201318.","journal-title":"Noncoding RNA Res Nov"},{"key":"3218_CR6","doi-asserted-by":"publisher","first-page":"e55102","DOI":"10.7554\/eLife.55102","volume":"9","author":"Q Hao","year":"2020","unstructured":"Hao Q, Zong X, Sun Q, Lin Y, Song YC, Hashemikhabir S, Hsu R, Kamran M, Chaudhary R, et al. The S-phase-induced LncRNA SUNO1 promotes cell proliferation by controlling YAP1\/H\u0130PPO signaling pathway. eLife. 2020;9:e55102.","journal-title":"eLife"},{"issue":"6","key":"3218_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.pan.2020.05.004","volume":"20","author":"H Zhu","year":"2020","unstructured":"Zhu H, Shan Y, Ge K, Lu J, Kong W, Jia C. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p. Pancreatology. 2020;20(6):1139\u201348.","journal-title":"Pancreatology"},{"key":"3218_CR8","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1002\/cam4.2245","volume":"8","author":"J Xu","year":"2019","unstructured":"Xu J, Guo J, Jiang Y, Liu Y, Fu Z, Xiong Z. Improved characterization of the relationship between long intergenic non-coding RNA Linc00152 and the occurrence and development of malignancies. Cancer Med. 2019;8:4722\u201331.","journal-title":"Cancer Med"},{"key":"3218_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.619915","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q, Wang X, Zhou L, Jiang M, Zhong G, Xu S, et al. A positive feedback loop of long noncoding RNA LINC00152 and KLF5 facilitates breast cancer growth. Front Oncol. 2021;11:619915.","journal-title":"Front Oncol"},{"key":"3218_CR10","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1038\/s41388-019-0812-8","volume":"38","author":"BS Tan","year":"2019","unstructured":"Tan BS, Yang MC, Singh S, Chou YC, Chen HY, Wang MY, et al. LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P. Oncogene. 2019;38:5612\u201326.","journal-title":"Oncogene"},{"key":"3218_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinform. 2016;14:42\u201354.","journal-title":"Genom Proteom Bioinform"},{"key":"3218_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111186","volume":"119","author":"J Fu","year":"2024","unstructured":"Fu J, Liu W, Liu S, Zhao R, Hayashi T, Zhao H, et al. Inhibition of YAP\/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells. Cell Signal. 2024;119:111186.","journal-title":"Cell Signal"},{"issue":"4","key":"3218_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2021.05.041","volume":"75","author":"MB Saleh","year":"2021","unstructured":"Saleh MB, Louvet A, Ntandja-Wandji LC, Boleslawski E, Gnemmi V, Lassailly G, Dubuquoy L. Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis. J Hepatol. 2021;75(4):912\u201323.","journal-title":"J Hepatol"},{"issue":"17","key":"3218_CR14","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/onc.2015.288","volume":"35","author":"G Hua","year":"2016","unstructured":"Hua G, Lv X, He C, Remmenga SW, Rodabough KJ, Dong J, Wang C. YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. Oncogene. 2016;35(17):2247\u201365.","journal-title":"Oncogene"},{"issue":"4","key":"3218_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"1\u20132","key":"3218_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.","journal-title":"J Immunol Methods"},{"issue":"2","key":"3218_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329\u201333.","journal-title":"Nat Protoc"},{"issue":"1","key":"3218_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mrrev.2012.08.001","volume":"752","author":"N Kramer","year":"2013","unstructured":"Kramer N, Walzl A, Unger C, Rosner M, Krupitza G, Hengstschl.ger M. AnDolznig H. In vitro cell migration and invasion assays. Mutat Research\/Reviews Mutat Res. 2013;752(1):10\u201324.","journal-title":"Mutat Research\/Reviews Mutat Res"},{"key":"3218_CR19","first-page":"89","volume-title":"Cancer stem cells: methods and protocols","author":"V Rajendran","year":"2017","unstructured":"Rajendran V, Jain MV. In vitro tumorigenic assay: colony forming assay for cancer stem cells. In: Papaccio G, Desiderio V, editors. Cancer stem cells: methods and protocols. New York, NY: Springer New York; 2017. pp. 89\u201395."},{"issue":"2","key":"3218_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020632","volume":"22","author":"K Taniue","year":"2021","unstructured":"Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2):632.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3218_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12349","volume":"50","author":"Y Yu","year":"2017","unstructured":"Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L. LINC00152: a pivotal oncogenic long non- coding RNA in human cancers. Cell Prolif. 2017;50(4):e12349.","journal-title":"Cell Prolif"},{"issue":"2","key":"3218_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.gendis.2021.08.012","volume":"10","author":"C Ou","year":"2023","unstructured":"Ou C, He X, Liu Y, et al. LncRNA cytoskeleton regulator RNA (CYTOR): diverse functions in metabolism, inflammation and tumorigenesis, and potential applications in precision oncology. Genes Dis. 2023;10(2):415\u201329.","journal-title":"Genes Dis"},{"issue":"9","key":"3218_CR23","volume":"2","author":"OV Grembergen","year":"2016","unstructured":"Grembergen OV, Bizet M, Bony EJ, Calonne E, Putmans P, Broh S, et al. Portraying breast cancers with long noncoding RNAs. Sci Adv. 2016;2(9):e160022.","journal-title":"Sci Adv"},{"issue":"1","key":"3218_CR24","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1634\/theoncologist.2018-0358","volume":"25","author":"H Wang","year":"2020","unstructured":"Wang H, Liu Y, Tang A. Prognostic values of long noncoding RNA linc00152 in various carcinomas: an updated systematic review and meta-analysis. Oncologist. 2020;25(1):e31-8.","journal-title":"Oncologist"},{"issue":"3","key":"3218_CR25","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2025.12804","volume":"29","author":"J Asberger","year":"2025","unstructured":"Asberger J, Ge I, Schmidt B, J\u00e4ger M, Weiss D, Berner K, et al. Long non-coding RNA signatures in breast cancer: properties as biomarkers? Exp Ther Med. 2025;29(3):54.","journal-title":"Exp Ther Med"},{"issue":"4","key":"3218_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.amjms.2024.07.012","volume":"368","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Lu J, Tong J, Yin Y, Zhang K. LncRNA CYTOR knockdown inhibits tumor development via regulating miR-503-5p\/PCSK9 in lung adenocarcinoma. Am J Med Sci. 2024;368(4):382\u201391.","journal-title":"Am J Med Sci"},{"issue":"5","key":"3218_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N. Transcription regulation by long non-coding rnas: mechanisms and disease relevance. Nat Rev Mol Cell Biol. 2024;25(5):396\u2013415.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"3218_CR28","first-page":"497","volume":"45","author":"Y Liu","year":"2020","unstructured":"Liu Y, Li M, Yu H, Piao H. The lncRNA CYTOR promotes Tamoxifen resistance in breast cancer cells via sponging with miR\u2013125a\u20135p. Int J Mol Med. 2020;45(2):497\u2013509.","journal-title":"Int J Mol Med"},{"issue":"5","key":"3218_CR29","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13057","volume":"22","author":"Q Tian","year":"2021","unstructured":"Tian Q, Yan X, Yang L, Liu Z, Yuan Z, Zhang Y. LncRNA CYTOR promotes cell proliferation and tumor growth via miR-125b\/SEMA4C axis in hepatocellular carcinoma. Oncol Lett. 2021;22(5):796.","journal-title":"Oncol Lett"},{"key":"3218_CR30","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19284","volume":"13","author":"H Lu","year":"2025","unstructured":"Lu H, Zhao Y, Zhang Y, Shi S, Hu H, Li X, et al. Long non-coding RNA CYTOR promotes the progression of melanoma via the miR-485-5p\/GPI axis. PeerJ. 2025;13:e19284.","journal-title":"PeerJ"},{"issue":"4","key":"3218_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Guan KL. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150(4):780\u201391.","journal-title":"Cell"},{"key":"3218_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.643515","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu S. LncRNA GHET1 promotes hypoxia-induced glycolysis, proliferation, and invasion in triple-negative breast cancer through the H\u0130PPO\/YAP signaling pathway. Front Cell Dev Biol. 2021;9:643515.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3218_CR33","first-page":"9","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2023;4(1):9\u201326.","journal-title":"Nat Cancer"},{"issue":"2","key":"3218_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/cells12020302","volume":"12","author":"SR Trampu\u017e","year":"2023","unstructured":"Trampu\u017e SR, van Riet S, Nordling \u00c5, Ingelman-Sundberg M. The role of CTGF in liver fibrosis induced in 3D human liver spheroids. Cells. 2023;12(2):302.","journal-title":"Cells"},{"issue":"6","key":"3218_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.trecan.2020.12.001","volume":"7","author":"YW Shen","year":"2021","unstructured":"Shen YW, Zhou YD, Chen HZ, Luan X, Zhang WD. Targeting CTGF in cancer: an emerging therapeutic opportunity. Trends Cancer. 2021;7(6):511\u201324.","journal-title":"Trends Cancer"},{"issue":"15","key":"3218_CR36","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3390\/cells11152363","volume":"11","author":"C Lv","year":"2022","unstructured":"Lv C, Yu H, Wang K, Chen C, Tang J, Han F, et al. ENO2 promotes colorectal cancer metastasis by interacting with the LncRNA CYTOR and activating YAP1-induced EMT. Cells. 2022;11(15):2363.","journal-title":"Cells"},{"issue":"14","key":"3218_CR37","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1093\/nar\/gki762","volume":"33","author":"X Lin","year":"2005","unstructured":"Lin X, Ruan X, Anderson MG, McDowell JA, Kroeger PE, Fesik SW, et al. siRNA-mediated off-target gene silencing triggered by a 7 Nt complementation. Nucleic Acids Res. 2005;33(14):4527\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3218_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1261\/rna.352507","volume":"13","author":"LM Alem\u00e1n","year":"2007","unstructured":"Alem\u00e1n LM, Doench J, Sharp PA. Comparison of siRNA-induced off-target RNA and protein effects. RNA. 2007;13(3):385\u201395.","journal-title":"RNA"},{"issue":"2","key":"3218_CR39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bbrc.2018.12.074","volume":"509","author":"X Shen","year":"2019","unstructured":"Shen X, Zhong J, Yu P, Zhao Q, Huang T. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein. Biochem Biophys Res Commun. 2019;509(2):448\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3218_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/cells9030623","volume":"9","author":"TT Liao","year":"2020","unstructured":"Liao TT, Yang MH. Hybrid epithelial\/mesenchymal state in cancer metastasis: clinical significance and regulatory mechanisms. Cells. 2020;9(3):623.","journal-title":"Cells"},{"issue":"10","key":"3218_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101118","volume":"8","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, et al. The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8(10):1118.","journal-title":"Cells"},{"key":"3218_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00155","volume":"5","author":"MK Jolly","year":"2015","unstructured":"Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, et al. Implications of the hybrid epithelial\/mesenchymal phenotype in metastasis. Front Oncol. 2015;5:155.","journal-title":"Front Oncol"},{"issue":"3","key":"3218_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. Emt transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212\u201326.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"3218_CR44","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1016\/j.clbc.2018.02.002","volume":"18","author":"N Yamashita","year":"2018","unstructured":"Yamashita N, Tokunaga E, Iimori M, Inoue Y, Tanaka K, Kitao H, Saeki H, Oki E, Maehara Y. Epithelial paradox: clinical significance of coexpression of E-cadherin and vimentin with regard to invasion and metastasis of breast cancer. Clin Breast Cancer. 2018;18(5):e1003\u20139.","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"3218_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7150\/ijbs.83586","volume":"20","author":"W Zhou","year":"2024","unstructured":"Zhou W, Lim A, Edderkaoui M, Osipov A, Wu H, Wang Q, Pandol S. Role of YAP signaling in regulation of programmed cell death and drug resistance in cancer. Int J Biol Sci. 2024;20(1):15.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"3218_CR46","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.18632\/oncotarget.2792","volume":"6","author":"MM Williams","year":"2015","unstructured":"Williams MM, Cook RS. Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance? Oncotarget. 2015;6(6):3519.","journal-title":"Oncotarget"},{"issue":"1","key":"3218_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1):20\u201338.","journal-title":"Apoptosis"},{"issue":"6","key":"3218_CR48","first-page":"4510","volume":"18","author":"H Zou","year":"2019","unstructured":"Zou H, Li H. Knockdown of long non-coding RNA LINC00152 increases cisplatin sensitivity in ovarian cancer cells. Exp Ther Med. 2019;18(6):4510\u20136.","journal-title":"Exp Ther Med"},{"issue":"3","key":"3218_CR49","doi-asserted-by":"publisher","first-page":"614","DOI":"10.21037\/jtd-22-59","volume":"14","author":"H Hu","year":"2022","unstructured":"Hu H, Chen C, Chen F, Sun N. LINC00152 knockdown suppresses tumorigenesis in non-small cell lung cancer via sponging miR-16-5p. J Thorac Dis. 2022;14(3):614\u201324.","journal-title":"J Thorac Dis"},{"issue":"11","key":"3218_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115183","volume":"26","author":"L Jahangiri","year":"2025","unstructured":"Jahangiri L. The mechanical properties of breast cancer cells and their surrounding microenvironment. Int J Mol Sci. 2025;26(11):5183.","journal-title":"Int J Mol Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03218-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:03:31Z","timestamp":1770393811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03218-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03218-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"103"}}